Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study. [electronic resource]
- Japanese journal of clinical oncology Nov 2016
- 1031-1041 p. digital